Phase I Study of RNA Oligonucleotide, MTL-CEBPA, Atezolizumab and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma.
Clinical trial NCT05097911 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05097911
- Sponsor
- National University Hospital, Singapore
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-02
- Primary completion
- 2026-04-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.